Peptide library / Immune & defense / Telavancin
Telavancin
A lipoglycopeptide antibiotic for resistant skin infections and hospital pneumonia.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Complicated skin infectionsFDA approved
- Hospital-acquired pneumoniaFDA approved
How it is thought to work
Telavancin blocks cell wall synthesis and disrupts the membrane of Gram-positive bacteria.
What the evidence shows
Trials showed non-inferiority to vancomycin.
Safety and unknowns
Boxed warnings cover harm to a fetus and higher mortality in patients with existing kidney impairment.
Regulatory status
FDA-approved as Vibativ in 2009.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Immune & defense
Thymalin
Wellness and performanceA thymus extract developed in the Soviet Union and promoted as an immune bioregulator.
Thymopentin
In clinical trialsA five amino acid fragment of thymopoietin used as an immune modulator in parts of Europe.
Polymyxin B
FDA-approvedA last-resort cyclic peptide antibiotic, close relative of colistin.
General information, not medical advice. Do not buy or inject unregulated peptides.